Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

On-Line Patient Portal Use By Caregivers in Pediatric Oncology: Are We Widening Sociodemographic Disparities?

Corinna L Schultz, MD, Suzanne M McCahan, PhD, H. Timothy Bunnell, PhD, Fang Fang Chen, PhD, Melissa A Alderfer, PhD

Blood (2019) 134 (Supplement_1): 2131.

https://doi.org/10.1182/blood-2019-131543

Published: 2019

Journal Articles

Framework to Identify and Prioritize Candidate Inherited Myeloid Malignancy Germline Variants Leveraging the BEAT AML Cohort

Daniel Bottomly, Nicola Long, Fei Yang, MD, Tiffany Lee, MD, Uma Borate, MD, Beth Wilmot, PhD, Adam S DuVall, MD, Andrea Monteblanco, BS, Karina Thiel-Klare, Gabby Dewson, BA, Richard D. Press, MD PhD, Cristina E. Tognon, Brian J. Druker, Jeffrey W. Tyner, Shannon K. McWeeney, PhD, Anupriya Agarwal, PhD

Blood (2019) 134 (Supplement_1): 1407.

https://doi.org/10.1182/blood-2019-132224

Published: 2019

Journal Articles

Informing Clinical Decision and Policy Making in Blood Related Disorders Using Targeted Next Generation Sequencing

Betoul Baz, PhD, Tarek Owaidah, MDFRCPA, Majed Dasouki, MD, Mohammed Abouelhoda, PhD, Dorota Monies, PhD, Nada Al Tassan, PhD

Blood (2019) 134 (Supplement_1): 5776.

https://doi.org/10.1182/blood-2019-122370

Published: 2019

Journal Articles

Characterization and Disease Management of Persons with Hemophilia A Treated with Emicizumab: A Survey Study of Hematologists in the US

Wendy E. Owens, MA, Anisha M. Patel, PhD, Kathleen Poulos, RN, Janet Bernard, BA, Janet Powers, MPH, MBA, Richard H. Ko, MD

Blood (2019) 134 (Supplement_1): 4941.

https://doi.org/10.1182/blood-2019-123730

Published: 2019

Journal Articles

POD24 in MZL: a means to an end or an end point in itself?

Matthew J. Maurer

Blood (2019) 134 (10): 787–788.

https://doi.org/10.1182/blood.2019002305

Published: 2019

Journal Articles

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Mahsen AlSaleh, MD, Tarek Owaidah, MD, Hazzaa Alzahrani, MD, Tahani Bin Ali, MD, Huda ElFaraidi, MD, Mahmoud Abu Riash, RN, Zikra Alkhayal, MD, AbdulKareem Al Momen, MD, Viqaruddin Mohammed, MSc, CCRP, Azzah AlZahrani, MD

Blood (2017) 130 (Supplement 1): 5587.

https://doi.org/10.1182/blood.V130.Suppl_1.5587.5587

Published: 2017

Journal Articles

Increased Eligibility for Attempting Treatment-Free Remission (TFR) with Frontline Nilotinib (NIL) vs Imatinib (IM) in Patients with Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia (CML): Results of a Stochastic Simulation Model

Francois-Xavier Mahon, MD PhD Professor, An Tran-Duy, Raechelle G. Ocampo, David Ray, PharmD, MBA, Estella Mendelson, BSRN, MBA, Aby Buchbinder, Pascal Edrich, Sonya J. Snedecor, PhD, Giuseppe Saglio

Blood (2015) 126 (23): 5154.

https://doi.org/10.1182/blood.V126.23.5154.5154

Published: 2015

Journal Articles

All Roads Lead to Rome: Phenotypic Channeling to Uniform Differentiation Structures from Diverse Leukemia Genotypes by Mass Cytometry

Garry Nolan, PhD

Blood (2013) 122 (21): SCI-22.

https://doi.org/10.1182/blood.V122.21.SCI-22.SCI-22

Published: 2013

Journal Articles

BK Virus Disease Following Allogeneic Stem Cell Transplantation: A Cohort Analysis

Nienke MG Rorije, Margaret M Shea, Gowri Satyanarayana, MD, Sarah P Hammond, MD, Vincent T Ho, MD, Lindsey R Baden, MD, Joseph H Antin, MD, Robert J Soiffer, MD, Francisco M Marty, MD

Blood (2012) 120 (21): 1927.

https://doi.org/10.1182/blood.V120.21.1927.1927

Published: 2012

Journal Articles

Early Mortality in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European Leukemianet MDS (EUMDS) Registry

Louise de Swart, Alex Smith, Pierre Fenaux, Guillermo Sanz, Eva Hellstrom-Lindberg, Argyris Symeonidis, Jaroslav Cermak, Ulrich Germing, MD, Reinhard Stauder, Otilia Georgescu, Marius MacKenzie, Luca Malcovati, Mette Skov Holm, Krzysztof Madry, MD, PhD, Sophie Park, Odile Beyne-Rauzy, Jackie Droste, David Bowen, Theo de Witte

Blood (2012) 120 (21): 3830.

https://doi.org/10.1182/blood.V120.21.3830.3830

Published: 2012

Journal Articles

Prognostic Impact of Comorbidities In A Cohort of 788 MDS Patients Based On A CIRS-G Derived Score. A MDS Piedmont Registry Prospective Study

Emanuela Messa, Daniela Gioia, Claudia Bertassello, Gianni Ciccone, Bernardino Allione, Daniela Cilloni, MD, PhD, Flavia Salvi, MD, Gianni Cametti, Monia Lunghi, Dario Ferrero, Roberto Freilone, MD, Margherita Bonferroni, Giuseppe Saglio, MD, Alessandro Levis, MD

Blood (2011) 118 (21): 1729.

https://doi.org/10.1182/blood.V118.21.1729.1729

Published: 2011

Journal Articles

A Worldwide Observational Registry Collecting Longitudinal Data on Management of Chronic Myeloid Leukemia Patients (The WORLD CML Registry) – 2nd Annual Interim Analysis

Ricardo Pasquini, MD, Jorge Cortes, MD, Hagop M. Kantarjian, MD, David Joske, MBBS, FRCPA, FRACP, Luis A Meillon, MD, Lidia Mongay, MD, PhD, MBA, John Reynolds, PhD, Timothy Hughes, MD, MBBS, Dong-Wook Kim, MD

Blood (2010) 116 (21): 2292.

https://doi.org/10.1182/blood.V116.21.2292.2292

Published: 2010

Journal Articles

The Population-Based ‘real world’ of Low Risk Myelodysplastic Syndromes; Second Interim Analysis of the European LeukemiaNet MDS Registry at 800 Registered New Patients

David Bowen, Alex Smith, Jackie Droste, Pierre Fenaux, MD, PhD, Argyris Symeonidis, Eva Hellstrom-Lindberg, MD, PhD, Guillermo F Sanz, MD, PhD, Jaroslav Cermak, MD, PhD, Otilia Georgescu, Ulrich Germing, Marius MacKenzie, Reinhard Stauder, Odile Beyne-Rauzy, Luca Malcovati, Theo de Witte

Blood (2010) 116 (21): 1867.

https://doi.org/10.1182/blood.V116.21.1867.1867

Published: 2010

Journal Articles

Re-Evaluation of the Efficacy of Azacitidine (AZA) In Patients From the AZA-001 Study with Higher-Risk Myelodysplastic Syndromes (MDS) Classified by WHO Criteria and WPSS Risk

Norbert Gattermann, MD, Guillermo F. Sanz, MD, PhD, Aristoteles Giagounidis, John F Seymour, MD, FRACP, Pierre Fenaux, MD, PhD, Valeria Santini, MD, Ghulam J. Mufti, DM, FRCP, FRCPath, Petra Muus, MD, PhD, Fernando Ramos, MD, Lela M. Lucy, MS, CL Beach, PharmD, Lewis R. Silverman, MD

Blood (2010) 116 (21): 4031.

https://doi.org/10.1182/blood.V116.21.4031.4031

Published: 2010

Journal Articles

Disease-Management of Low- and Intermediate-1 Risk Myelodysplastic Syndromes: Report on 800 Newly Diagnosed MDS Patients From the European LeukemiaNet MDS Registry

Louise de Swart, Alex Smith, Pierre Fenaux, Argyris Symeonidis, Eva Hellström-Lindberg, Guillermo Sanz, Jaroslav Cermak, Otilia Georgescu, Ulrich Germing, Marius MacKenzie, Odile Beyne-Rauzy, Luca Malcovati, Reinhard Stauder, Jackie Droste, David Bowen, Theo de Witte

Blood (2010) 116 (21): 2917.

https://doi.org/10.1182/blood.V116.21.2917.2917

Published: 2010

Journal Articles

European Registry for Low Risk and Intermediate-1 Risk MDS: Base Line Report On First 400 Registered Patients.

T. M. de Witte, Alex Smith, Jackie Droste, Pierre Fenaux, Argyris Symeonidis, Eva Hellstrom-Lindberg, MD, PhD, Guillermo Sanz, Jaroslav Cermak, Otilia Georgescu, Ulrich Germing, Marius MacKenzie, Reinhard Stauder, MD, Odile Beyne Rauzy, David T. Bowen, MD

Blood (2009) 114 (22): 3811.

https://doi.org/10.1182/blood.V114.22.3811.3811

Published: 2009

Journal Articles

A Worldwide Observational Registry Collecting Longitudinal Data On the Management of CML Patients (The WORLD CML Registry) - Summary of the First 1001 Patients.

Ricardo Pasquini, MD, Jorge Cortes-Franco, MD, Hagop M. Kantarjian, MD, David Joske, MBBS, FRCPA, FRACP, Zhixiang Shen, MD, PhD, Luis Meillon, MD, Lidia Mongay, MD, PhD, MBA, Dawn F. Eng, Jim Wang, PhD, Timothy P. Hughes, MD, MBBS, Dong-Wook Kim, MD, PhD

Blood (2009) 114 (22): 4267.

https://doi.org/10.1182/blood.V114.22.4267.4267

Published: 2009

Journal Articles

Diagnostic and Disease Management Algorithms for Gaucher Disease: A Guide for Haematologists

Pramod K Mistry, Maria Domenica Cappellini, Elena Lukina, Hayri Özsan, Sara Mach Pascual, Hanna Rosenbaum, Maria Helena Solano, Zachary Simon Spigelman, Jesús Villarrubia, Nora Patricia Watman, Gero Massenkeil

Blood (2008) 112 (11): 4648.

https://doi.org/10.1182/blood.V112.11.4648.4648

Published: 2008

Journal Articles

Quality of Life in Myelodysplastic Syndromes (MDS): Results from U.S. & European Patient Forums.

Kathy Heptinstall, RN, BSN, the MDS Foundation’s Board of Directors

Blood (2006) 108 (11): 2623.

https://doi.org/10.1182/blood.V108.11.2623.2623

Published: 2006

Journal Articles

Over-Expression of the Local Bone Marrow Renin-Angiotensin System in Acute Myeloid Leukemia.

Yavuz Beyazit, MD, Salih Aksu, MD, Ibrahim Celalettin Haznedaroglu, MD, Murat Kekilli, MD, Muge Misirlioglu, MD, Serdar Tuncer, MD, Ebru Koca, MD, Deniz Cetiner, MD, Yahya Buyukasik, MD, Nilgun Sayinalp, MD, Hakan Goker, MD, Osman Ilhami Ozcebe, MD

Blood (2005) 106 (11): 4567.

https://doi.org/10.1182/blood.V106.11.4567.4567

Published: 2005

NARROW

On-Line Patient Portal Use By Caregivers in Pediatric Oncology: Are We Widening Sociodemographic Disparities?

Framework to Identify and Prioritize Candidate Inherited Myeloid Malignancy Germline Variants Leveraging the BEAT AML Cohort

Informing Clinical Decision and Policy Making in Blood Related Disorders Using Targeted Next Generation Sequencing

Characterization and Disease Management of Persons with Hemophilia A Treated with Emicizumab: A Survey Study of Hematologists in the US

POD24 in MZL: a means to an end or an end point in itself?

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Increased Eligibility for Attempting Treatment-Free Remission (TFR) with Frontline Nilotinib (NIL) vs Imatinib (IM) in Patients with Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia (CML): Results of a Stochastic Simulation Model

All Roads Lead to Rome: Phenotypic Channeling to Uniform Differentiation Structures from Diverse Leukemia Genotypes by Mass Cytometry

BK Virus Disease Following Allogeneic Stem Cell Transplantation: A Cohort Analysis

Early Mortality in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European Leukemianet MDS (EUMDS) Registry

Prognostic Impact of Comorbidities In A Cohort of 788 MDS Patients Based On A CIRS-G Derived Score. A MDS Piedmont Registry Prospective Study

A Worldwide Observational Registry Collecting Longitudinal Data on Management of Chronic Myeloid Leukemia Patients (The WORLD CML Registry) – 2nd Annual Interim Analysis

The Population-Based ‘real world’ of Low Risk Myelodysplastic Syndromes; Second Interim Analysis of the European LeukemiaNet MDS Registry at 800 Registered New Patients

Re-Evaluation of the Efficacy of Azacitidine (AZA) In Patients From the AZA-001 Study with Higher-Risk Myelodysplastic Syndromes (MDS) Classified by WHO Criteria and WPSS Risk

Disease-Management of Low- and Intermediate-1 Risk Myelodysplastic Syndromes: Report on 800 Newly Diagnosed MDS Patients From the European LeukemiaNet MDS Registry

European Registry for Low Risk and Intermediate-1 Risk MDS: Base Line Report On First 400 Registered Patients.

A Worldwide Observational Registry Collecting Longitudinal Data On the Management of CML Patients (The WORLD CML Registry) - Summary of the First 1001 Patients.

Diagnostic and Disease Management Algorithms for Gaucher Disease: A Guide for Haematologists

Quality of Life in Myelodysplastic Syndromes (MDS): Results from U.S. & European Patient Forums.

Over-Expression of the Local Bone Marrow Renin-Angiotensin System in Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only